If you have been NEWLY DIAGNOSED START HERE
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! But meanwhile -- Videos from...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Probably the most immediate potentially practice-changing presentation from ASCO was the Japanese J-ALEX study in the subset of about 4-5% of patients...
But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available!
But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available!
This past event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock